Position in CGC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$317,915
New position
Shares Held
335,000
first reported quarter
Ownership
0.079%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Derivatives in CGC
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$317,915
PutShares
335,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Sculptor Capital LP holds $53,834,707 across 4 Drug Manufacturers - Specialty & Generic names. CGC ranks #3 (0.6% of the industry book) .
All Filings in CGC
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $317,915 | 335,000 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $317,915 | 335,000 | Put | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||